⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 6, 2025

Supplementary Fig. S1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy

Zhijun Zhou Yang Cai Hao Yuan Qun Chen Sophia W. Zhao Jingxuan Yang Mingyang Liu Alex X. Arreola Yu Ren Chao Xu Lacey R. McNally Michael S. Bronze Courtney W. Houchen Kuirong Jiang Wei R. Chen Yuqing Zhang Min Li

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: Ferroptosis levels significantly correlate with overall survival in cancer immunotherapy patients.
KEY EVIDENCE: Analysis of data from the Van-Allen and Hugo cohorts supports the association between ferroptosis and patient outcomes.
APPROACH: The work examined ferroptosis levels in cancer patients undergoing immunotherapy from two separate cohorts.
SIGNIFICANCE: This research advances understanding of biomarkers in cancer treatment, potentially guiding therapy decisions.

Implication

Correlation of ferroptosis levels with overall survival in cancer patients indicates its potential as a biomarker.

Abstract

Supplementary Fig. S1. Correlation between ferroptosis level and overall survival of patients in Van-Allen cohort and Hugo cohort.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/689a0fa0e6551bb0af8d19dc https://doi.org/10.1158/2767-9764.29836669

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Fig. S2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
2Supplementary Fig. S3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
3Supplementary Fig. S4 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
4Supplementary Fig. S6 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
5Supplementary Fig. S5 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025

Figure 1 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
Figure 2 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025
Figure 3 from Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy2025